Promakhos Therapeutics
Pagliuca Harvard Life Lab
Promakhos Therapeutics
Developing oral, non-immunosuppressive, small molecules to cure chronic inflammatory disorders.
About Promakhos Therapeutics
School
Harvard Faculty of Arts and Sciences, Harvard Medical School
Programs
Pagliuca Harvard Life Lab
Promakhos Therapeutics is developing cures for autoimmune diseases. Millions of people suffer from autoimmunity, yet there is currently no cure. Existing treatments focus on blocking the immune system to manage symptoms, often providing temporary relief. In contrast, Promakhos addresses the root cause of the problem. We aspire to deliver curative therapies by developing treatments inspired by the body's resident bacteria. These treatments aim to modulate humans’ innate ability to resolve inflammation and promote healing.